Click to share on Facebook (Opens in new window) Click to share on Twitter (Opens in new window) Click to share on Pinterest (Opens in new window) The world under our oceans is vastly unexplored.

Foresight Diagnostics, which provides ultra-sensitive minimal residual disease (MRD) detection technology, today announced the launch of the PRECISE-HL clinical trial with the University of Washington ...

“My goal, I guess, is to try and inspire as many of them, to give them the courage to try to do something.” It was her passion to inspire more women to get into sport that led her to her ...

Nivolumab plus ipilimumab is being reviewed by the FDA as a first-line treatment for advanced colorectal cancer, with a decision expected by June 2025. The FDA accepted the supplemental biologics ...

If a traditional CPAP machine isn't for you, you might consider the Inspire sleep apnea device as an alternative treatment option. Here's what you need to know. Taylor Leamey writes about all ...

Adjuvant therapy with nivolumab (Opdivo, “nivo”) continues to show disease-free survival (DFS) and overall survival (OS) benefits compared with placebo among patients with muscle-invasive ...

Update: February 21 (2:51 PM ET): We’ve updated our Fitbit Inspire 4 rumor hub with new information about Fitbit’s devices in general. At the end of my Fitbit Inspire 3 review, I gave the ...

Evaluating the efficacy of cabozantinib in patients with advanced renal cell carcinoma with bone metastasis: An open-label phase 2 study. This is an ASCO Meeting Abstract from the 2025 ASCO ...